BIOMAT Database Logo BIOMAT Database Logo

[Pancytopenia and Pneumocystis carinii pneumonia associated with low dose methotrexate pulse therapy for rheumatoid arthritis--case report and review of literature]. 1996

S Kitsuwa, and K Matsunaga, and M Kawai, and T Tsuzi, and K Kato, and K Tani, and T Okubo
First Department of Internal Medicine at Urafune Hospital, Yokohama-city.

Low-dose weekly pulse MTX therapy is effective for rheumatoid arthritis (RA) and is used for patients with RA who are unresponsive to conventional disease-modifying antirheumatic drugs (DMARDs). We used MTX to a 62-year-old man with RA who had received DMARDs for 5 years. MTX was effective for RA but after 12 weeks MTX therapy started, he complicated pancytopenia and developed Pneumocystis carinii pneumonia. We reviewed all RA patients reported in Japan and in the world from 1965, complicated with Pancytopenia (37 cases) and Pneumocystis carinii pneumonia (13 cases) after MTX therapy. Results were as following; (1) MTX should not be used with TMP-SMX. and risk factors for pancytopenia were (2) age over 60 years old (3) renal hypofunction (4) use of NSAID.

UI MeSH Term Description Entries
D007674 Kidney Diseases Pathological processes of the KIDNEY or its component tissues. Disease, Kidney,Diseases, Kidney,Kidney Disease
D008297 Male Males
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010198 Pancytopenia Deficiency of all three cell elements of the blood, erythrocytes, leukocytes and platelets. Pancytopenias
D011020 Pneumonia, Pneumocystis A pulmonary disease in humans occurring in immunodeficient or malnourished patients or infants, characterized by DYSPNEA, tachypnea, and HYPOXEMIA. Pneumocystis pneumonia is a frequently seen opportunistic infection in AIDS. It is caused by the fungus PNEUMOCYSTIS JIROVECII. The disease is also found in other MAMMALS where it is caused by related species of Pneumocystis. P carinii Pneumonia,P. carinii Pneumonia,P. jirovecii Pneumonia,PCP Pneumonia,Pneumocystis Pneumonia,Pneumocystosis,Pneumonia, Interstitial Plasma Cell,PCP Infection,Pneumocystis carinii Pneumonia,Pneumocystis jirovecii Pneumonia,Pneumonia, Pneumocystis carinii,Infection, PCP,P carinii Pneumonias,P. carinii Pneumonias,P. jirovecii Pneumonias,PCP Infections,PCP Pneumonias,Pneumocystis Pneumonias,Pneumocystoses,Pneumonia, P carinii,Pneumonia, P. carinii,Pneumonia, P. jirovecii,Pneumonia, PCP,Pneumonia, Pneumocystis jirovecii,Pneumonias, PCP
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000075202 Contraindications A condition or factor associated with a recipient that makes the use of a drug, procedure, or physical agent improper or inadvisable. Contraindications may be absolute (life threatening) or relative (higher risk of complications in which benefits may outweigh risks). Contraindications, Physical Agent,Medical Contraindications,Agent Contraindication, Physical,Agent Contraindications, Physical,Contraindication,Contraindication, Medical,Contraindication, Physical Agent,Contraindications, Medical,Medical Contraindication,Physical Agent Contraindication,Physical Agent Contraindications
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents

Related Publications

S Kitsuwa, and K Matsunaga, and M Kawai, and T Tsuzi, and K Kato, and K Tani, and T Okubo
Low dose methotrexate therapy for rheumatoid arthritis complicated by pancytopenia and Pneumocystis carinii pneumonia.
August 1991, The Journal of rheumatology,
S Kitsuwa, and K Matsunaga, and M Kawai, and T Tsuzi, and K Kato, and K Tani, and T Okubo
Pneumocystis carinii pneumonia associated with low dose methotrexate treatment for rheumatoid arthritis.
January 1994, Scandinavian journal of rheumatology,
S Kitsuwa, and K Matsunaga, and M Kawai, and T Tsuzi, and K Kato, and K Tani, and T Okubo
[A case of pneumocystis carinii pneumonia associated with low dose methotrexate treatment for rheumatoid arthritis and trimethoprim-sulphamethoxazole induced pancytopenia].
June 2004, Arerugi = [Allergy],
S Kitsuwa, and K Matsunaga, and M Kawai, and T Tsuzi, and K Kato, and K Tani, and T Okubo
[Pneumocystis carinii pneumonia associated with low dose methotrexate treatment for malignant rheumatoid arthritis].
August 1995, Ryumachi. [Rheumatism],
S Kitsuwa, and K Matsunaga, and M Kawai, and T Tsuzi, and K Kato, and K Tani, and T Okubo
[Fatal outcome of pneumocystis-carinii pneumonia under low-dose methotrexate and prednisone therapy for chronic rheumatoid arthritis. Case report and literature review].
April 1994, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
S Kitsuwa, and K Matsunaga, and M Kawai, and T Tsuzi, and K Kato, and K Tani, and T Okubo
Pneumocystis carinii pneumonia complicating low dose methotrexate treatment for rheumatoid arthritis.
March 1991, Thorax,
S Kitsuwa, and K Matsunaga, and M Kawai, and T Tsuzi, and K Kato, and K Tani, and T Okubo
Pneumocystis carinii pneumonia complicating low dose methotrexate treatment for rheumatoid arthritis.
January 1992, Thorax,
S Kitsuwa, and K Matsunaga, and M Kawai, and T Tsuzi, and K Kato, and K Tani, and T Okubo
Pneumocystis carinii pneumonia associated with methotrexate therapy in rheumatoid arthritis.
August 1991, The Journal of rheumatology,
S Kitsuwa, and K Matsunaga, and M Kawai, and T Tsuzi, and K Kato, and K Tani, and T Okubo
Pneumocystis carinii pneumonia following methotrexate therapy for rheumatoid arthritis.
October 1983, Arthritis and rheumatism,
S Kitsuwa, and K Matsunaga, and M Kawai, and T Tsuzi, and K Kato, and K Tani, and T Okubo
Severe pancytopenia associated with low-dose methotrexate therapy for rheumatoid arthritis.
December 2001, The Annals of pharmacotherapy,
Copied contents to your clipboard!